Journal
NATURE REVIEWS DRUG DISCOVERY
Volume 19, Issue 3, Pages 149-150Publisher
NATURE PORTFOLIO
DOI: 10.1038/d41573-020-00016-0
Keywords
-
Funding
- National Nature Science Foundation of China [31571368, 31871324, 81730064]
- National Science and Technology Major Project [2018ZX10715004]
- Natural Science Foundation of Hunan Province [2018JJ3713]
- Hunan Youth Elite Project [2018RS3006]
- Project of Innovation-Driven Plan of Central South University [2016CX031]
Ask authors/readers for more resources
Therapeutic options in response to the 2019-nCoV outbreak are urgently needed. Here, we discuss the potential for repurposing existing antiviral agents to treat 2019-nCoV infection (now known as COVID-19), some of which are already moving into clinical trials.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
